Sun Pharma has announced late-breaking data from two pivotal Phase-3 clinical trials (reSURFACE 1 and 2) achieving the primary endpoint…
PRIME previews the 7th International Congress in Aesthetic Dermatology (ICAD 2016), taking place in Bangkok, Thailand, on 24–26 November 2016….
Allergan acquires medical dermatology and aesthetic medicine company Anterios to expand neurotoxin pipeline
Acquisition adds global rights to novel NDS™ platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product
Imran Majid and Gousia Sheikh review the use of microneedling for the treatment of acne scars and a growing number of new applications, such as transdermal drug delivery and hair restoration
The number of skin and soft tissue infections (SSTI) has skyrocketed owing to the spread of meticillin-resistant Staphylococcus aureus (MRSA)….
Lumenis grows its flagship laser hair removal offering with the introduction of LightSheer® INFINITY™
LightSheer® INFINITY™ is one of the most advanced solutions for laser hair removal and treats the broadest range of skin types
Dr Matteo Tretti Clementoni discusses his experience using lasers for the rejuvenation of the skin, and particularly the ResurFX device from Lumenis
M22™ is a modular multi-application platform for the treatment of over 30 skin conditions and hair removal. Used by physicians around…
The American Society for Dermatologic Surgery (ASDS) and the Dermatologic & Aesthetic Surgery International League (DASIL) have approved a new…